114 related articles for article (PubMed ID: 35225565)
1. Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess?
Nair AG
Indian J Ophthalmol; 2022 Mar; 70(3):1024-1025. PubMed ID: 35225565
[No Abstract] [Full Text] [Related]
2. Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).
MohanaSundaram A; Sathanantham ST; Chinchole V; Patil B; Velayutham R
Int J Surg; 2021 Oct; 94():106110. PubMed ID: 34534704
[No Abstract] [Full Text] [Related]
3. Commentary: COVID-19-associated mucormycosis: The ongoing battle.
Nair AG
Indian J Ophthalmol; 2021 Dec; 69(12):3683-3684. PubMed ID: 34827022
[No Abstract] [Full Text] [Related]
4. Commentary on "Mucormycosis co-infection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int J Surg 2021, 92:106031) - A pulmonary perspective.
Gangakhedkar MR; Gupta R
Int J Surg; 2021 Oct; 94():106116. PubMed ID: 34537396
[No Abstract] [Full Text] [Related]
5. Mucormycosis: An unanticipated progeny of COVID-19.
Shrestha GS; Bhandari S; Lamsal R; Gurung U
JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
[TBL] [Abstract][Full Text] [Related]
6. Response to: COVID-19-associated mucormycosis and evolving evidence.
Sarda R; Swain S; Ray A; Wig N
QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346
[No Abstract] [Full Text] [Related]
7. In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: a systematic review and meta-analysis.
Sinha A; Bhaskar SMM
Int Forum Allergy Rhinol; 2022 Mar; 12(3):313-317. PubMed ID: 34633150
[No Abstract] [Full Text] [Related]
8. COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors.
Deepak P; Rao MR; Mandadi K
J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598140
[No Abstract] [Full Text] [Related]
9. Mucormycosis in COVID-19 recovered patients.
Kumar A
J Med Virol; 2022 Apr; 94(4):1272-1273. PubMed ID: 34905224
[No Abstract] [Full Text] [Related]
10. [COVID-19 associated mucormycosis. A case in Argentina].
Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
[TBL] [Abstract][Full Text] [Related]
11. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Mucormycosis and COVID-19.
Yadav S
J Contemp Dent Pract; 2021 Aug; 22(8):855. PubMed ID: 34753834
[TBL] [Abstract][Full Text] [Related]
13. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
Pasero D; Sanna S; Liperi C; Piredda D; Branca GP; Casadio L; Simeo R; Buselli A; Rizzo D; Bussu F; Rubino S; Terragni P
Infection; 2021 Oct; 49(5):1055-1060. PubMed ID: 33331988
[TBL] [Abstract][Full Text] [Related]
14. Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis.
Kaur H; Kanaujia R; Rudramurthy SM
Indian J Med Microbiol; 2021; 39(4):473-474. PubMed ID: 34266698
[No Abstract] [Full Text] [Related]
15. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Devnath P; Dhama K; Tareq AM; Emran TB
Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
[No Abstract] [Full Text] [Related]
16. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
Ravindra K; Ahlawat A
Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
[TBL] [Abstract][Full Text] [Related]
17. Mucormycosis in COVID-19 patients.
Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
[TBL] [Abstract][Full Text] [Related]
18. Covid-19 associated Mucormycosis: A case report.
Shrestha O; Sharma Baral R
J Nepal Health Res Counc; 2021 Sep; 19(2):414-416. PubMed ID: 34601541
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and Mucormycosis: Time we Answer Questions?
Tandon A; Tandon S
J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
